Market
What will be the operational status of Sanofi's Beijing facility by the end of 2025?
2
Resolution / Starting Odds
Fully operational • 25%
Partially operational • 25%
Not operational • 25%
Other • 25%
Sanofi's operational updates or industry reports
Story
Sanofi to Invest €1 Billion ($1.05 Billion) in Fourth Beijing Insulin Production Base Amid China-EU Trade Tensions
Dec 2, 2024, 09:14 PM
Sanofi, the French pharmaceutical giant, has announced plans to invest approximately 1 billion euros (around $1.05 billion) to establish a new insulin production facility in Beijing. This investment represents Sanofi's largest single investment in China to date and marks a significant move amid ongoing trade tensions between China and the European Union. The new manufacturing base will be Sanofi's fourth production and supply site in the country. The announcement was made following a memorandum of understanding signed recently, highlighting the company's commitment to expanding its operations in the region.
View original story
Similar markets
Production started • 25%
None of the above • 25%
Construction completed • 25%
Construction started • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
500 to 1000 • 25%
Less than 500 • 25%
More than 1500 • 25%
1000 to 1500 • 25%
No • 50%
Yes • 50%
Project unaffected • 25%
Project delayed • 25%
Project halted • 25%
Project expedited • 25%
Increase by 5-10% • 25%
Increase by over 10% • 25%
Increase by less than 5% • 25%
No significant change • 25%
10% to 15% increase • 25%
More than 15% increase • 25%
Less than 5% increase • 25%
5% to 10% increase • 25%
More than 30% • 25%
10% to 20% • 25%
Less than 10% • 25%
20% to 30% • 25%